Maryland Prescription Drug Affordability Board

​Title 14- Independent Agencies

Subtitle 01- Prescription Drug Affordability Board

Chapter

01- General Provisions

              .01 Definitions

              .02 Rules of Constructions

              .03 Open Meetings

              .04 Confidential, Trade-Secret and Proprietary Information

              .05 Public Comment Procedures

02- Prescription Drug Affordability Fund

              .01 Prescription Drug Affordability Fund

              .02 Fee Assessment, Exemption, and Collection

              .03 Amount of Assessment

              .04 Use of Funds

              .05 Surplus Funds

03- Public Information Act

              .01 Scope

              .02 Policy

              .03 Definitions

              .04 Official Custodian

              .05 Request for Public Records

              .06 Written Request May Be Required

              .07 Contents of Written Request

              .08 Addressee

              .09 Response to Request

              .10 Notice to Person Potentially Affected by Disclosure

              .11 Electronic Records

              .12 Public Record Destroyed or Lost

              .13 Availability of Judicial and Administrative Review

              .14 Disclosure Against Public Interest

              .15 Fees

              .16 Time and Place of Inspection

              .17 Sociological Information 

04- Cost Review Study Process

              .01 Public Reporting of Drug Affordability Issues

              .02 Identifying Drugs Eligible for Cost Review

              .03 Selecting Drugs for Cost Review

              .04 Request for Information for Cost Review

              .05 Cost Review Study​